The first is an African American woman who had suffered from severe fatigue for ten years. On investigation her liver was enlarged, she had holes in her spleen. Dr Weinstein started her off on Low Dose Naltrexone (LDN). Within a month she was feeling better. Within five months the spleen was improved, within ten months her spleen was normal and her liver had improved dramatically. The patient was feeling much better.
Another African American female patient who had a very prolonged history of pulmonary sarcoidosis, 26 years. In the last few years this patient had been on home oxygen all day and night, she had shortness of breath and a dry cough. Dr Weinstock prescribed her Low Dose Naltrexone and within two months she noticed less fatigue and was off oxygen except for use when she was particularly active and she was able to come off her prednisone.
The third case is a 35 year old white male who had ventricular tachycardia and pulmonary sarcoidosis.
The final case study is about a patient with sarcoidosis in the hip joints and knees, the patient suffered severe fatigue and brain fog. This patient had a rapid response to LDN, within a week she was much more mobile and clear headed.
Dr Weinstock concludes that Low Dose Naltrexone (LDN) is a good alternative to prednisone and immunomodulators and it’s safe.
Thank you for listening to this presentation. All past conference presentations can be found on our website, www.ldnresearchtrust.org